Navigation Links
More Women Choosing 'Preventive' Double Mastectomy
Date:10/22/2007

tamin D may help slow breast cancer cell growth, the researchers speculated. But the results aren't an endorsement to sunbathe. Instead, they said, vitamin D from diet and supplements may someday be recommended to help reduce breast cancer risk.

More information

To learn more about contralteral prophylactic mastectomy, visit The Society of Surgical Oncology.



SOURCES: Todd Tuttle, M.D., chief of surgical oncology and associate professor of surgery, University of Minnesota Medical School, Minneapolis; S. Eva Singletary, M.D., professor of surgical oncology, University of Texas M.D. Anderson Cancer Center, Houston; Oct. 22 2007, Journal of Clinical Oncology, online; The Society of Surgical Oncology, Arlington Heights, Ill.; American Cancer Society, Atlanta


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with CAD
2. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
3. Starvation in pregnant women can cause heart disease to their children
4. Women suffer from sexual dysfunction too
5. Brisk Walking lowers memory loss in women
6. Young womens woes
7. Young womens woes
8. Women find difficulty in calling it Quits
9. FDA approves new device to treat womens bleeding disorder
10. Women recognise faces better
11. Women more susceptible to brain damage from ecstasy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...ogs have surprised researchers by showing that the...an toddlers. The study, by Austrian researchers,... when it comes to a physical problem-solving test....en researchers first observed how several children...
...tgrave, PhD, an expert on HIV prevention at the Jo...argeted campaign of testing and counseling aimed ...e effective than the mass patient screening propos...and Prevention (CDC). Holtgraves study is the fir...
...nday against South Korea's hard-drinking culture w...d economic losses, officials said . The campaign f...re to enhance public awareness of the dangers of e...ealth and Welfare said. "South Koreans consider o...
...heimer drug in the form of a milkshake. This milks...tarved by the damages of the Alzheimer disease . I...g large scale testing against the brain destroying...d Ketasyn, is a new approach to treating dementia....
Other Medicine News:Health News:Dogs Reasoning on Par With Human Toddlers: Study 2Health News:Targeted HIV Testing An Effective Way to Screen HIV Patients 2Health News:A Milky Alternative to Alzheimer Drug 2
(Date:9/3/2008)...Wrong Children Studied. Wrong,Conclusions Reached.... Centers for Disease,Control and Prevention (CDC) ...en the MMR vaccine and autism. The National Autism... dispel the growing public concern over a,vaccine-...cerning design,and methodology., For years, paren...
(Date:9/3/2008)...scular Disease Awareness Month, CHARLOTTESVILLE, ...cals,LLC, a clinical-stage drug-development compan...nmet medical needs, announced today that it has be...ial of its lead drug,candidate trans sodium crocet...the clinicaltrials.gov Website, is investigating T...
(Date:9/3/2008)... Phase 3 Plans with FDA, PRINCETON, N.J., Sept. 3...ed today that it successfully completed two key cl...new, innovative low-dose, once-weekly,contracepti...nal product,code AG-200-15. The Phase 2b safety an...oint of ovulation suppression, cycle control and s...
(Date:9/3/2008)...swire-FirstCall/ -- A sub-analysis of,the TRITON-T...rasugrel,compared with clopidogrel significantly r...(7.4 percent vs. 9.7 percent, p<0.0001), regardles...f an artery-opening,procedure known as percutaneou... spontaneously during the longer-term maintenance ...
Breaking Medicine Technology:CDC Misses Target With Flawed MMR/Autism Study 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 2Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 3Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 4Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 5Prasugrel Significantly Reduced New or Recurrent Heart Attacks in Both Acute and Longer-Term Settings Following PCI, Compared with Clopidogrel 6Biannual Antibiotics May Cut Major Cause of Blindness in Africa 12290 1Biannual Antibiotics May Cut Major Cause of Blindness in Africa 12290 2NIST NCI SAIC partner on new method for detecting HER2 breast cancer 12288 1NIST NCI SAIC partner on new method for detecting HER2 breast cancer 12288 2DATATRAK International Management to Host Conference Call on February 26 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007 12285 1DATATRAK International Management to Host Conference Call on February 26 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007 12285 2DATATRAK International Management to Host Conference Call on February 26 2008 to Discuss Fourth Quarter and Full Year Operating Results for 2007 12285 3XTENT Announces 2007 Financial Results 12282 1XTENT Announces 2007 Financial Results 12282 2XTENT Announces 2007 Financial Results 12282 3XTENT Announces 2007 Financial Results 12282 4XTENT Announces 2007 Financial Results 12282 5XTENT Announces 2007 Financial Results 12282 6
....--(BUSINESS WIRE)--Apr 25, 2007 - BioDelivery,Sci... today,statistically significant results with BEMA... pain in its pivotal Phase III efficacy,clinical t...ievement of the primary efficacy endpoint of the t... compared to placebo., The results demonstrated th...
...mark; April 25, 2007 - Genmab A/S (CSE: GEN),annou...th,ofatumumab (HuMax-CD20™) in patients with...oral presentation at the 2007,Annual European Cong...n, which will include new results from the double-...umumab, along with data,from the previous interim ...
Other Medicine Technology:BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 2BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 3BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 4BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 5BDSI Announces Positive Phase III Clinical Trial Results for BEMA,Fentanyl 6
Tank Blotting System. Designed for Western, Northern, or Southern Blotting. Transfer up to three gels with dimensions as large as 15cm x 21.5cm. Includes and internal cooling base for temperature
... proven electrophoretic transfer apparatus incorpo...ltimate in field uniformity. Its design allows for... when coupled with a low voltage power source such...ts/cm. The result is exceptionally rapid and exact...
...lot cell, a component of Bio-Rad's modular mini el...resis Systems), provides rapid, high-quality blott...ransfers two 7.5 x 10 cm gels in just 1 hour. Cool... absorbs heat generated during transfers. The Mini...
Includes PowerPac 200 power supply. Flexibility for a Range of Parameters. Quantitative Transfers. Native Enzyme, High Intensity, or Overnight Transfers. Faster, Higher-Efficiency Transfers via Pl
Medicine Products: